Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.8075 USD | -5.51% | +8.39% | +3.53% |
Kurzporträt
Mitarbeiterzahl: 20
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Gil Efron
CEO | Chief Executive Officer | 57 | 11.10.18 |
Lior Fhima
DFI | Director of Finance/CFO | - | 02.11.22 |
Ido Morpurgo
COO | Chief Operating Officer | 51 | 01.08.20 |
Hadas Reuveni
CTO | Chief Tech/Sci/R&D Officer | 56 | 01.01.17 |
Chief Tech/Sci/R&D Officer | 61 | 09.01.20 | |
Isaac Israel
BRD | Director/Board Member | 44 | 01.10.12 |
Simcha Rock
BRD | Director/Board Member | 73 | 11.07.13 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 47 | 01.07.16 |
William Berlin
PRN | Corporate Officer/Principal | - | - |
General Counsel | 55 | 01.01.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Eric Rowinsky
CHM | Chairman | 67 | 02.10.19 |
Yael Margolin
BRD | Director/Board Member | 70 | 20.12. |
Simcha Rock
BRD | Director/Board Member | 73 | 11.07.13 |
Ido Agmon
BRD | Director/Board Member | 46 | 27.06.16 |
Robert Gagnon
BRD | Director/Board Member | 49 | 03.03.21 |
Director/Board Member | 53 | 19.05.21 | |
Isaac Israel
BRD | Director/Board Member | 44 | 01.10.12 |
Ori Hershkovitz
BRD | Director/Board Member | 49 | 29.12.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 274 951 217 | 273 888 717 ( 99,61 %) | 0 | 99,61 % |
Unternehmenskontakt
Purple Biotech Ltd.
Science Park 4 Oppenheimer Street
7670104, Rehovot
+972 3 933 3121
http://ww.purple-biotech.comSektor
Quartalsumsätze - Abweichungsrate
% 1. Jan. | Kap. | |
---|---|---|
+11.91% | 118 Mrd. | |
+11.60% | 106 Mrd. | |
-4.68% | 24.28 Mrd. | |
-0.82% | 21.96 Mrd. | |
-10.12% | 18.16 Mrd. | |
-42.12% | 16.37 Mrd. | |
-17.47% | 15.56 Mrd. | |
+2.77% | 13.63 Mrd. | |
+34.58% | 12.27 Mrd. |
- Börse
- Aktien
- A1CY4T Aktie
- A2QLTP Aktie
- Unternehmen Purple Biotech Ltd